O425 Efficacy and safety of maraviroc in treatment-experienced (TE) patients infected with R5 HIV-1: 96-week combined analysis of the MOTIVATE 1 and 2 studies
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.